• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导多能干细胞中的线粒体重设与代谢重编程及线粒体疾病建模

Mitochondrial resetting and metabolic reprogramming in induced pluripotent stem cells and mitochondrial disease modeling.

作者信息

Hsu Yi-Chao, Chen Chien-Tsun, Wei Yau-Huei

机构信息

Institute of Biomedical Sciences, Mackay Medical College, New Taipei City, 252, Taiwan.

Department of Medicine, Mackay Medical College, New Taipei City, 252, Taiwan.

出版信息

Biochim Biophys Acta. 2016 Apr;1860(4):686-93. doi: 10.1016/j.bbagen.2016.01.009. Epub 2016 Jan 15.

DOI:10.1016/j.bbagen.2016.01.009
PMID:26779594
Abstract

BACKGROUND

Nuclear reprogramming with pluripotency factors enables somatic cells to gain the properties of embryonic stem cells. Mitochondrial resetting and metabolic reprogramming are suggested to be key early events in the induction of human skin fibroblasts to induced pluripotent stem cells (iPSCs).

SCOPE OF REVIEW

We review recent advances in the study of the molecular basis for mitochondrial resetting and metabolic reprogramming in the regulation of the formation of iPSCs. In particular, the recent progress in using iPSCs for mitochondrial disease modeling was discussed.

MAJOR CONCLUSIONS

iPSCs rely on glycolysis rather than oxidative phosphorylation as a major supply of energy. Mitochondrial resetting and metabolic reprogramming thus play crucial roles in the process of generation of iPSCs from somatic cells.

GENERAL SIGNIFICANCE

Neurons, myocytes, and cardiomyocytes are cells containing abundant mitochondria in the human body, which can be differentiated from iPSCs or trans-differentiated from fibroblasts. Generating these cells from iPSCs derived from skin fibroblasts of patients with mitochondrial diseases or by trans-differentiation with cell-specific transcription factors will provide valuable insights into the role of mitochondrial DNA heteroplasmy in mitochondrial disease modeling and serves as a novel platform for screening of drugs to treat patients with mitochondrial diseases.

摘要

背景

利用多能性因子进行核重编程可使体细胞获得胚胎干细胞的特性。线粒体重置和代谢重编程被认为是诱导人皮肤成纤维细胞成为诱导多能干细胞(iPSC)过程中的关键早期事件。

综述范围

我们综述了iPSC形成调控中线粒体重置和代谢重编程分子基础研究的最新进展。特别讨论了利用iPSC进行线粒体疾病建模的最新进展。

主要结论

iPSC依赖糖酵解而非氧化磷酸化作为主要能量供应。因此,线粒体重置和代谢重编程在体细胞生成iPSC的过程中起着关键作用。

普遍意义

神经元、肌细胞和心肌细胞是人体中含有丰富线粒体的细胞,它们可从iPSC分化而来或由成纤维细胞转分化而来。从线粒体疾病患者的皮肤成纤维细胞衍生的iPSC或通过细胞特异性转录因子转分化来生成这些细胞,将为线粒体DNA异质性在线粒体疾病建模中的作用提供有价值的见解,并作为筛选治疗线粒体疾病药物的新平台。

相似文献

1
Mitochondrial resetting and metabolic reprogramming in induced pluripotent stem cells and mitochondrial disease modeling.诱导多能干细胞中的线粒体重设与代谢重编程及线粒体疾病建模
Biochim Biophys Acta. 2016 Apr;1860(4):686-93. doi: 10.1016/j.bbagen.2016.01.009. Epub 2016 Jan 15.
2
Generation and Characterization of Induced Pluripotent Stem Cells from Patients with mtDNA Mutations.线粒体DNA突变患者诱导多能干细胞的产生与鉴定
Methods Mol Biol. 2016;1353:65-75. doi: 10.1007/7651_2015_258.
3
Mitochondrial regulation in pluripotent stem cells.多能干细胞中的线粒体调控。
Cell Metab. 2013 Sep 3;18(3):325-32. doi: 10.1016/j.cmet.2013.06.005. Epub 2013 Jul 11.
4
Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.重编程及重编程细胞分化过程中的线粒体与代谢重塑
Stem Cells Dev. 2015 Jun 1;24(11):1366-73. doi: 10.1089/scd.2014.0561. Epub 2015 Apr 2.
5
Mitochondrial Disease-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization.线粒体疾病特异性诱导多能干细胞模型:生成与表征
Methods Mol Biol. 2016;1353:323-42. doi: 10.1007/7651_2014_195.
6
The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells.人诱导多能干细胞中衰老相关的线粒体/氧化应激途径受到抑制。
Stem Cells. 2010 Apr;28(4):721-33. doi: 10.1002/stem.404.
7
Current understanding and future perspectives of the roles of sirtuins in the reprogramming and differentiation of pluripotent stem cells.目前对沉默调节蛋白在多能干细胞重编程和分化中的作用的理解和未来展望。
Exp Biol Med (Maywood). 2018 Mar;243(6):563-575. doi: 10.1177/1535370218759636.
8
Induced pluripotent stem cells (iPSCs) for modeling mitochondrial DNA disorders.用于模拟线粒体DNA疾病的诱导多能干细胞(iPSC)
Methods Mol Biol. 2015;1265:349-56. doi: 10.1007/978-1-4939-2288-8_24.
9
Revisiting Mitochondrial Function and Metabolism in Pluripotent Stem Cells: Where Do We Stand in Neurological Diseases?重新审视多能干细胞中的线粒体功能与代谢:在神经疾病领域我们处于什么位置?
Mol Neurobiol. 2017 Apr;54(3):1858-1873. doi: 10.1007/s12035-016-9714-8. Epub 2016 Feb 18.
10
Concise Review: Induced Pluripotent Stem Cell-Based Drug Discovery for Mitochondrial Disease.简明综述:基于诱导多能干细胞的药物发现用于治疗线粒体疾病。
Stem Cells. 2017 Jul;35(7):1655-1662. doi: 10.1002/stem.2637. Epub 2017 May 22.

引用本文的文献

1
BRG1 improves reprogramming efficiency by enhancing glycolytic metabolism.BRG1通过增强糖酵解代谢提高重编程效率。
Cell Mol Life Sci. 2024 Dec 6;81(1):482. doi: 10.1007/s00018-024-05527-2.
2
Development and characterization of cell models harbouring mtDNA deletions for in vitro study of Pearson syndrome.用于 Pearson 综合征体外研究的携带有 mtDNA 缺失的细胞模型的开发和特性鉴定。
Dis Model Mech. 2022 Mar 1;15(3). doi: 10.1242/dmm.049083.
3
Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.
特异质性药物性肝损伤(iDILI)的临床前模型:迈向预测
Acta Pharm Sin B. 2021 Dec;11(12):3685-3726. doi: 10.1016/j.apsb.2021.11.013. Epub 2021 Nov 18.
4
Gaining Insight into Mitochondrial Genetic Variation and Downstream Pathophysiology: What Can i(PSCs) Do?深入了解线粒体遗传变异及其下游病理生理学:i(PSCs)能做什么?
Genes (Basel). 2021 Oct 22;12(11):1668. doi: 10.3390/genes12111668.
5
Cellular Models for Primary CoQ Deficiency Pathogenesis Study.原发性 CoQ 缺乏症发病机制研究的细胞模型。
Int J Mol Sci. 2021 Sep 22;22(19):10211. doi: 10.3390/ijms221910211.
6
MitoCellPhe reveals mitochondrial morphologies in single fibroblasts and clustered stem cells.MitoCellPhe 揭示了单个成纤维细胞和聚集干细胞中的线粒体形态。
Am J Physiol Cell Physiol. 2021 Oct 1;321(4):C735-C748. doi: 10.1152/ajpcell.00231.2021. Epub 2021 Sep 1.
7
Generation of somatic mitochondrial DNA-replaced cells for mitochondrial dysfunction treatment.用于治疗线粒体功能障碍的体线粒体 DNA 替换细胞的生成。
Sci Rep. 2021 May 25;11(1):10897. doi: 10.1038/s41598-021-90316-1.
8
Advances in mt-tRNA Mutation-Caused Mitochondrial Disease Modeling: Patients' Brain in a Dish.线粒体tRNA突变所致线粒体疾病模型的进展:盘中的患者大脑
Front Genet. 2021 Jan 12;11:610764. doi: 10.3389/fgene.2020.610764. eCollection 2020.
9
Role of purines in regulation of metabolic reprogramming.嘌呤在代谢重编程调控中的作用。
Purinergic Signal. 2019 Dec;15(4):423-438. doi: 10.1007/s11302-019-09676-z. Epub 2019 Sep 6.
10
Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation.体外扩增人造血干细胞需要协调细胞重编程、线粒体重塑和 p53 激活。
Blood Adv. 2018 Oct 23;2(20):2766-2779. doi: 10.1182/bloodadvances.2018024273.